Efficacy of BIPAMS for Restless Legs Syndrome in Adults With Multiple Sclerosis: A Pilot Study

Completed · Not applicable

Conditions studied: Multiple Sclerosis, Restless Legs Syndrome

In brief

The purpose of this study is to evaluate the efficacy of a 16-week behavioral intervention for increasing physical activity and reducing restless legs syndrome (RLS) severity in persons with multiple sclerosis (MS) and RLS. The study includes a proposed sample of 20 persons with MS and RLS that will be randomized into either a 16-week behavioral intervention arm aimed at increasing physical activity or a 16-week wait-list control arm.

Key facts

Study ID

NCT04061681

Run by

University of Alabama at Birmingham

People needed

15

Starts

2020-01-01

Expected to finish

2020-11-23

Last updated by the study team

2020-12-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of multiple sclerosis
• Relapse free in the past 30 days
• Positive screen for restless legs syndrome
• Non-active (not engaging in 30 minutes of activity per day on more than 2 days per week in the previous six months)
• Ambulatory without assistance
• Internet and email access

You may not qualify if…

• Diagnosis of radiculopathy, peripheral edema, peripheral neuropathy, iron deficiency (i.e., anemia) renal disease, or diabetes
• Screen at moderate or high risk for undertaking strenuous or maximal exercise

Where it is running

• University of Alabama at Birmingham — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.